IDH1 and glioblastoma: Analysis of TCGA data demonstrates that IDH1 is upregulated in several malignancies, including anaplastic large cell lymphoma, glioblastoma, and pancreatic ductal adenocarcinomas, and it is associated with poor prognosis among leukemia patients [120,121,122,123].